Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 039140/0989 | |
| Pages: | 3 |
| | Recorded: | 07/13/2016 | | |
| Attorney Dkt #: | BHC 131064 PCT-US |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
11/28/2017
|
Application #:
|
15029215
|
Filing Dt:
|
04/13/2016
|
|
Publication #:
|
|
Pub Dt:
|
09/08/2016
| | | | |
|
Title:
|
PHARMACEUTICAL DOSAGE FORMS COMPRISING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE
|
|
|
Assignee
|
|
|
|
|
| MÜLLERSTR. 178 |
| BERLIN, GERMANY 13353 |
|
|
Correspondence name and address
|
| |
IP SPRING
|
| |
180 N. LA SALLE
|
| |
SUITE 3700
|
| |
CHICAGO, IL 60601
|
Search Results as of:
05/31/2024 09:57 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
